Total Payments
$12,217
2024 Payments
$550.43
Companies
43
Transactions
764
Medicare Patients
2,337
Medicare Billing
$248,174
Payment Breakdown by Category
Food & Beverage$12,065 (98.8%)
Education$151.65 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,065 | 760 | 98.8% |
| Education | $151.65 | 4 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,805 | 110 | $0 (2024) |
| ABBVIE INC. | $1,251 | 85 | $0 (2024) |
| Lilly USA, LLC | $1,155 | 73 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $944.08 | 63 | $0 (2024) |
| Merck Sharp & Dohme LLC | $856.75 | 59 | $0 (2023) |
| Amgen Inc. | $775.28 | 44 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $729.97 | 45 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $636.44 | 36 | $0 (2024) |
| Allergan, Inc. | $488.75 | 40 | $0 (2020) |
| Astellas Pharma US Inc | $438.69 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $550.43 | 24 | Lilly USA, LLC ($146.47) |
| 2023 | $1,597 | 83 | AbbVie Inc. ($458.33) |
| 2022 | $1,978 | 134 | Novo Nordisk Inc ($454.58) |
| 2021 | $1,809 | 124 | AbbVie Inc. ($371.66) |
| 2020 | $1,484 | 94 | Allergan, Inc. ($253.29) |
| 2019 | $1,086 | 76 | Amgen Inc. ($166.80) |
| 2018 | $1,671 | 111 | Takeda Pharmaceuticals U.S.A., Inc. ($264.67) |
| 2017 | $2,043 | 118 | Merck Sharp & Dohme Corporation ($344.96) |
All Payment Transactions
764 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Gastroenterology | ||||||
| 06/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $112.21 | General |
| Category: Biological | ||||||
| 03/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PAIN | ||||||
| 03/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: RESPIRATORY | ||||||
| 01/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Diabetes | ||||||
| 12/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 326 | 373 | $40,975 | $31,849 |
| 2022 | 12 | 569 | 707 | $68,265 | $50,933 |
| 2021 | 14 | 686 | 2,019 | $115,985 | $89,536 |
| 2020 | 13 | 756 | 2,048 | $113,865 | $75,856 |
Total Patients
2,337
Total Services
5,147
Medicare Billing
$248,174
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 80 | 80 | $12,000 | $10,705 | 89.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 82 | $12,300 | $7,738 | 62.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 83 | $8,300 | $5,779 | 69.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $5,175 | $4,512 | 87.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 64 | 64 | $1,280 | $1,234 | 96.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $1,200 | $1,176 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $720.00 | $705.60 | 98.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 144 | 144 | $21,600 | $19,969 | 92.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 106 | $15,900 | $10,572 | 66.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 118 | $11,800 | $8,688 | 73.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 18 | 91 | $9,100 | $3,944 | 43.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 108 | 108 | $2,185 | $2,126 | 97.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $1,950 | $1,936 | 99.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 28 | $2,100 | $1,158 | 55.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $1,100 | $1,078 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $690.00 | $676.80 | 98.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $540.00 | $535.80 | 99.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 18 | $900.00 | $195.43 | 21.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 16 | $400.00 | $55.14 | 13.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 184 | 184 | $27,600 | $26,402 | 95.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 13 | 1,260 | $28,980 | $20,646 | 71.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 159 | $23,850 | $16,222 | 68.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 110 | 136 | $13,600 | $9,363 | 68.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 20 | 25 | $6,875 | $5,425 | 78.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 61 | 61 | $4,575 | $3,968 | 86.7% |
About Dr. Amy Smith, M.D
Dr. Amy Smith, M.D is a Internal Medicine healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821215567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Smith, M.D has received a total of $12,217 in payments from pharmaceutical and medical device companies, with $550.43 received in 2024. These payments were reported across 764 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($12,065).
As a Medicare-enrolled provider, Smith has provided services to 2,337 Medicare beneficiaries, totaling 5,147 services with total Medicare billing of $248,174. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Wynnewood, PA
- Active Since 04/20/2007
- Last Updated 02/20/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821215567
Products in Payments
- VRAYLAR (Drug) $804.28
- FARXIGA (Drug) $539.47
- UBRELVY (Drug) $528.09
- Trintellix (Drug) $523.83
- TRULICITY (Drug) $513.89
- TRINTELLIX (Drug) $507.81
- JANUVIA (Drug) $486.83
- JARDIANCE (Drug) $449.36
- Prolia (Biological) $416.59
- Ozempic (Drug) $347.75
- Saxenda (Drug) $346.02
- MOUNJARO (Drug) $317.97
- Livalo (Drug) $284.68
- TRADJENTA (Drug) $247.81
- BELSOMRA (Drug) $222.18
- ELIQUIS (Drug) $216.84
- Wegovy (Drug) $202.72
- TRELEGY ELLIPTA (Drug) $194.21
- XARELTO (Drug) $188.20
- Rybelsus (Drug) $185.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wynnewood
Dr. Bonnie Goldmann, M.d, M.D
Internal Medicine — Payments: $127,503
Internal Medicine $127,503
Dr. Ryan Reber, D.o, D.O
Internal Medicine — Payments: $90,073
Internal Medicine $90,073
Amanulla Khaji
Internal Medicine — Payments: $82,548
Internal Medicine $82,548
Dr. David Cohen, Md, MD
Internal Medicine — Payments: $41,001
Internal Medicine $41,001
Dr. M Susan Burke, Md, MD
Internal Medicine — Payments: $40,158
Internal Medicine $40,158
Hyon Ju Park, Md, MD
Internal Medicine — Payments: $13,459
Internal Medicine $13,459